Other urogenital trichomoniasis
ICD-10 A59.09 is a billable code used to indicate a diagnosis of other urogenital trichomoniasis.
Urogenital trichomoniasis is a sexually transmitted infection caused by the protozoan parasite Trichomonas vaginalis. It primarily affects the urogenital tract, leading to symptoms such as vaginal discharge, itching, and discomfort in women, while men may experience urethritis and prostatitis. The infection is often asymptomatic, particularly in men, which complicates diagnosis and increases transmission risk. Diagnosis is typically made through laboratory testing of vaginal or urethral secretions. Treatment involves the use of antibiotics, most commonly metronidazole or tinidazole, which are effective in eradicating the parasite. Contact tracing is crucial in managing the spread of trichomoniasis, as partners of infected individuals should also be tested and treated to prevent reinfection. Public health initiatives emphasize the importance of safe sexual practices and regular screenings, particularly in high-risk populations. The condition can lead to complications such as increased susceptibility to HIV and adverse pregnancy outcomes if left untreated.
Detailed patient history, laboratory test results, and treatment plans.
Diagnosis and management of trichomoniasis in patients with multiple STIs.
Consideration of patient demographics and sexual history for accurate coding.
Documentation of symptoms, examination findings, and treatment protocols.
Management of symptomatic women presenting with vaginal discharge.
Need for thorough documentation of sexual history and partner treatment.
Used when laboratory confirmation of trichomoniasis is needed.
Document the reason for the test and patient symptoms.
Infectious disease specialists may order this test more frequently.
The primary treatment for other urogenital trichomoniasis is metronidazole or tinidazole, which are effective in eradicating the infection.
